Soluble P selectin levels in chronic liver disease: Relationship to disease severity

Hepato-Gastroenterology

Volumn 54, Issue 74, 2007, Pages 466-469

  Vardareli, Eser ^a,b   Saricam, Tülay ^a   Demirustu, Canan ^a   Gulbas, Zafer ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Department of Biostatistic ^*  (Turkey)

Author keywords

Hemostatic abnormalities; Liver disease; sP selectin

Indexed keywords

ANTITHROMBIN III; PADGEM PROTEIN;

ADULT; ARTICLE; BLOOD CLOTTING; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOPPLER FLOWMETER; FEMALE; FIBRINOLYSIS; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MALE; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

BLOOD COAGULATION TESTS; FEMALE; FIBRINOLYSIS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; THROMBOPHILIA;

EID: 34248191667     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Amitrano L, Guardascione MA, Brancaccio V, Balzano A: Coagulation disorders in liver disease. Seminars in Liver Disease 2002; 22:83-96.
2. Kelly DA, Tuddenham EG: Haemostatic defects in liver disease. Gut 1986; 27:339-349.
3. Mammen EF: Coagulation defects in liver disease. Med Clin North Am 1994; 78:545-554.
4. Rapaport SI: Coagulation problems in liver disease. Blood Coagul Fibrinolysis 2000; 11(Suppl):569-575.
5. Rubin MH, Weston MJ, Langley PG, White Y, Williams R: Platelet function in chronic liver disease: relationship to disease severity. Dig Dis Sci 1979; 24:197-202.
6. Panasiuk A, Prokopowicz D, Zak J, Matowicka-Karna J, Osada J, Wysocka J: Activation of blood platelets in chronic hepatitis and liver cirrhosis P selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4. Hepatogastroenterology 2001; 48:818-822.
7. Davi G, Ferro D, Basili S, et al: Increased thromboxane metabolites excretion in liver cirrhosis. Thromb Haemost 1998; 79:747-751.
8. Blann AD, Lip GY: Hypothesis: Is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997; 128:135-138.
9. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD: Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000; 97:13835-13840.
10. Ferroni P, Mammarella A, Martini F, et al: Increased soluble P-selectin levels in hepatitis C virus related chronic hepatitis: Correlation with viral load. J Investig Med 2001; 49:407-412.
11. Fijnheer R, Frijns CJM, Korteweg J, et al: The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77:1081-1085.
12. Hu KQ, Yu AS, Tiyyagura L, Redeker AG, Reynolds TB: Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 2001; 96:1581-1586.
13. Segal H, Cottam S, Potter D, Hunt BJ: Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantation. Hepatology 1997; 25:683-688.
14. Pernambuco JRB, Langley PG, Hughes RD, Izumi S, Williams R: Activation of the fibrinolytic system in patients with fulminant liver failure. Hepatology 1993; 18:1350-1356.
15. Pirisi M, Fabris C, Ceriello A, et al: Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: evidence against a cause-effect relationship. Acta Gastroenterol Belg 1995; 58:230-237.